Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.

NCT04932850 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Virus Disease

Interventions

BIOLOGICAL: MAD0004J08
OTHER: Placebo

Sponsor

Toscana Life Sciences Sviluppo s.r.l.

Collaborators

[object Object]